The detailed price of moboxetinib succinate in 2024 has been released

Mobocertinib (Mobocertinib) is a prescription drug used to treat adults with non-small cell lung cancer: that is locally advanced or has spread to other parts of the body (metastatic) and cannot be removed with surgery, and Having an abnormal EGFR gene caused by an insertion mutation in exon20, the disease worsens during or after platinum-containing chemotherapy. Medical staff will conduct a test to make sure moboxetinib is right for the patient. It is not known whether mobosetinib is safe and effective in children.

Mobosetinib may cause serious side effects, including changes in the heart's electrical activity called QTc prolongation and torsade de pointes. QTc prolongation can cause irregular heartbeats, which are life-threatening and may lead to death. Doctors check a patient's heart's electrical activity with a test called an electrocardiogram (ECG) and do blood tests to check electrolytes before starting treatment with the drug and during treatment.

The original drug of moboxetinib is currently on the market in China and is sold under the name of moboxetinib succinate capsules. However, due to the short time it has been on the market and it has not yet been included in medical insurance, patients need to pay for the drug in full. It is reported that the price of each box of 40mg*112 tablets is around 40,000 yuan, which is very expensive. Other versions of Mobotinib include the Hong Kong version of the original drug Mobotinib, Specifications40mg*30 capsules per boxThe price is more than RMB 7,000 (the price may fluctuate due to exchange rates).

Generic drugs of Mobotinib have also been put on the market for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory40mg*120 pills per boxThe pricemay be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.